For localized information and support, would you like to switch to your country-specific website for {0}?
Events
36th Congress of the European Society of Clinical Microbiology & Infectious Diseases
ESCMID Global 2026
17 -21 April 2026
Munich, Germany
36th Congress of the European Society of Clinical Microbiology and Infectious Diseases
Ahead of care
Roche Diagnostics helps infectious disease clinicians stay ahead of care today while preparing for tomorrow’s challenges — supporting clearer decisions and stronger diagnostic pathways.
Thank you for joining in Munich, Germany Roche at ESCMID Global 2026, one of the largest and foremost global congresses in Clinical Microbiology & Infectious Diseases, for an engaging in-person event. This year the congress brought together leading experts from across diverse fields to share their latest cutting-edge research and collaborate on today’s most pressing challenges — from antimicrobial resistance to emerging pathogens.
It was a pleasure to interact with so many visitors at our immersive booth and discover how, together, we can stay ahead of care for infectious diseases. We hope you enjoyed our multifaceted program aimed to help you:
- Discover how you can enhance your operational workflow with the next generation of high-efficiency fully automated platforms
- Gain valuable medical insights into how to manage testing demands with multiplex PCR solutions
- Explore how you can leverage broad portfolios for your infectious disease challenges
- Learn from industry-leading experts on a wider variety of topics
Roche in-booth talks
Munich, Germany / 17-21 April, 2026
Staying ahead of care
Sign up for session recordings
We hosted engaging in-person events at the booth where expert speakers from around the world shared and discussed their experiences in infectious disease management. Explore further details about the topics covered in our sessions below:
- Evaluation of alternative specimen types using current and future versions of the cobas® eplex respiratory panel
- Syndromic testing of respiratory viruses: Evaluation of alternative and less invasive sample types
- Performance Evaluation of the Roche cobas® eplex Blood Culture Identification Panels in Routine Clinical Microbiology
- Clinical performance evaluation of a point-of-care PCR test for Bordetella species: a new tool to help break the transmission chain of pertussis
- Closing the Diagnostic Gap: High-Accuracy Point-of-Care Testing for STIs
- At-home self-sampling and STI diagnostics – Focus on new applications for the dried blood spot
- Bridging the Gap: Integrating Tuberculosis Diagnostics and Management in a World of Diversity
- Elecsys Dengue IgM immunoassay - A new and automated serology assay for the detection of Dengue infection at the acute critical stage of dengue fever
- Automation and digital innovation: Building a resilient, high-throughput molecular workarea
- Application of Sequencing by Expansion (SBX) in Infectious Diseases
Roche symposium
Sunday, 19 April 2026,
Innovations in microbiology: Advanced diagnostics for timely, accessible intervention
Sign up for session recordings
Diagnosing infections accurately and rapidly is a constant challenge in clinical microbiology. While advanced diagnostics offer powerful new tools, ensuring they are timely, accessible, and effectively integrated into clinical practice is crucial for intervention. How can we best leverage these innovations to improve patient care?
In this session, experts explored forward-thinking strategies and practical innovations surrounding the future of clinical microbiology, the implementation of molecular diagnostic systems for critical tests, and new approaches to TB biomarker discovery that move beyond traditional methods.
Agenda:
Bridging the gap in microbiology: Realizing advances in diagnostics and access across the globe
Katharina Kranzer, PhD
Health Research Unit Zimbabwe & London School of Hygiene and Tropical Medicine
From molecular detection to clinical decision: Integrating microbiology BCID testing and templated reporting comments for guided treatment of bloodstream infections
Mateu Espasa, MD
Hospital Clínic de Barcelona
Novel non-sputum-based biomarkers for TB diagnosis: Finding the missing millions
Michael Hoelscher, MD
LMU Munich
Chair: Nina Germic, PhD, Medical Affairs Lead, Roche Diagnostics Solutions, Rotkreuz
Innovation and pipeline theater
Munich, Germany / 18-19 April, 2026
Staying ahead of care
Sign up for session recordings
Modern clinical laboratories are at the forefront of a shifting diagnostic landscape, moving toward greater flexibility, automation, and scalability. This session series explores how cutting-edge molecular and serological solutions are addressing global health challenges—from gastrointestinal infections and Dengue fever to the global elimination of Tuberculosis.
Sign up to watch the recordings and come examine how integrated Roche solutions are streamlining workflows, enhancing analytical performance, and ultimately aiming to elevate the standard of patient care.
Agenda:
The flexible syndromic testing: Unlocking value with molecular gastrointestinal panels
Erin McElvania, PhD, D(ABMM) Endeavor Health, IL, USA
Organiser: Pedro L. Rodriguez, PhD, Roche Molecular Systems | GenMark
Streamlining dengue diagnostics with automation and Integrated Roche solutions
Carolin Bier, PhD, Roche Molecular Systems | Core Lab
Beyond the benchmark: Elevating TB diagnostics with the new Elecsys IGRA TB
Markus Eckl & Qian Feng, Roche Diagnostics Solutions
Organiser: Nina Germic, PhD, Roche Molecular Systems | Core Lab
Couldn't join us in Munich?
Come and enjoy a virtual ESCMID 2026 experience! We are happy to announce that all recordings from our multifaceted program will be available for you to watch on demand.
Register now for more information
Complete this form to stay up to date with all things to do with Roche at ESCMID 2026! You will gain access to our exclusive ESCMID 2026 webpage, where you can explore the recordings of our in-booth talks and all other session videos after the event.